Saturday, August 25, 2018

Are you Interested?
Stroke 2018 invites you to a great #platform to exhibit & showcase your skills & #research works to the world of #Neurology. Submit your #abstract and get chance to participate & update yourself by #attending this #great event @Vienna, Austria.

Thursday, August 23, 2018

Our Keynote Speaker | Stroke 2018

We welcome our for the upcoming meeting on Disorders & is to be held in on 22-23, 2018.

Join us and Explore the Modern Techniques and Developments of & .
For more details:
For Abstract Submission:

Friday, August 17, 2018

Stroke 2018 Invites you all

On behalf of Pulsus group, we are inviting all the participants from all over the world to attend our conference entitled “ 6th International Conference on Neurodegenerative Disorders and Stroke” to be held on October 22-232018 in ViennaAustria.

Stroke 2018 has been planning and aiming to stimulate new techniques for treatment of neurodegenerative disorders and stroke that would be beneficial for the neurosurgery.

The conference will be organized around the theme of ‘Novel Approaches & Developments in Neurodegenerative Disorders and Stroke.

Monday, August 13, 2018

Preventive treatments for ischemic stroke | Stroke 2018

After emergency procedures, your doctor will evaluate the health of your arteries and determine what needs to be done to prevent another ischemic stroke.

Lifestyle changes

Post-stroke preventive measures mainly focus on improving cardiovascular health. This might mean lowering your blood pressure and managing your blood sugar and cholesterol, or lipid, levels.
It’ll likely include a combination of exercisea healthier diet, and medications. If you smoke, quitting smoking is an important lifestyle change for stroke prevention.

Carotid endarterectomy

This procedure is often performed on people who’ve had an ischemic stroke due to a blocked carotid artery. The carotid arteries are the major blood vessels in the neck that supply blood to the brain. For this procedure, your surgeon will remove plaques and blockages from these arteries in order to improve blood flow and decrease the risk of future stroke.
This surgery carries the risks associated with any surgery. There’s also the risk that it may trigger another stroke if plaques or blood clots are released during the surgery. Protective measures are used to help reduce these risks.
#Stroke2018  #Strokeconferences  #Neurologyevent  #Conferences  #Vienna

Friday, August 3, 2018

Complications associated with a massive stroke | Stroke 2018

Complications and resulting impairments become more serious depending on the severity of the stroke. Complications can include the following:
Rehabilitation services can help minimize complications and may include working with:
  • a physical therapist to restore movement
  • an occupational therapist to learn how to perform daily tasks, such as activities involving personal hygiene, cooking, and cleaning
  • speech therapist to improve speaking ability
  • psychologist to help cope with feelings of anxiety or depression
#Stroke2018  #Strokeconferences  #Strokeconference  #NeurologyConferences #Event

Wednesday, August 1, 2018

Multiple Sclerosis | Stroke 2018

MS is a chronic illness involving your central nervous system. The immune system attacks myelin, which is the protective layer around nerve fibers. This causes inflammation and scar tissue, or lesions. This can make it hard for your brain to send signals to the rest of your body. Types of MS include:

Relapsing-remitting MS (RRMS)

RRMS involves clear relapses of disease activity followed by remissions. During remission periods, symptoms are mild or absent and there’s no disease progression. RRMS is the most common form of MS at onset.

Clinically isolated syndrome (CIS)

CIS involves one episode of symptoms lasting at least 24 hours. These symptoms are due to demyelination in your central nervous system.
The two types of episodes are monofocal and multifocal. A monofocal episode means one lesion causes one symptom. A multifocal episode means you have more than one lesion and more than one symptom.
Although these episodes are characteristic of MS, they aren’t enough to prompt a diagnosis. If lesions similar to those that occur with MS are present, you’re more likely to receive a diagnosis of RRMS. If these lesions aren’t present, you’re less likely to develop MS.

Primary-progressive MS (PPMS)

Neurological function becomes progressively worse from the onset of your symptoms if you have PPMS. However, short periods of stability can occur.
Progressive-relapsing MS was a term previously used for progressive MS with clear relapses. This is now called PPMS. The terms “active” and “not active” are used to describe disease activity.

Secondary-progressive MS (SPMS)

SPMS occurs when RRMS transitions into the progressive form. You may still have noticeable relapses, in addition to gradual worsening of function or disability.
Treatment for multiple sclerosis
No cure is available for MS, but multiple treatment options exist.
If you have RRMS, disease-modifying medications are designed to slow disease progression and lower your relapse rate.
Self-injectable disease-modifying drugs include glatiramer (Copaxone) and beta interferons, such as:
  • Avonex
  • Betaseron
  • Extavia
  • Plegridy
  • Rebif
Oral medications for RRMS include:
  • dimethyl fumarate (Tecfidera)
  • fingolimod (Gilenya)
  • teriflunomide (Aubagio)
Intravenous infusion treatments for RRMS include:
  • alemtuzumab (Lemtrada)
  • natalizumab (Tysabri)
  • mitoxantrone (Novantrone), which is for severe MS only
Disease-modifying drugs aren’t effective in treating progressive MS.
Your doctor can prescribe corticosteroids, such as methylprednisolone (Medrol) and prednisone (Deltasone) to treat relapses.
Other treatments may ease your symptoms and improve your quality of life. Because MS is different for everyone, treatment depends on your specific symptoms. For most, a flexible approach is necessary.